CAUWENBERGH GEERT (President & CEO) received a stock award from PHIO PHARMACEUTICALS CORP.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/29/2018ACC: 0001209191-18-056341
DirectorOfficer· President & CEO
Since Aug 2018
+18.52K
Net shares
Net buyer
$8.1K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
18.52K acquired
Non-Derivative Transactions1
Common stock, $0.0001 par value
Direct
Shares
+18.52K
Price / share
$0.44
Trade value
$8.10K
% of position
14.7%
10/26/2018
126.08K→144.59K
Total
Net shares
+18.52K
Net value
$8.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.0001 par value Direct | 10/26/2018 | A · Award | +18.52K | $0.44 | $8.10K | 14.7% | 126.08K | 144.59K |
| Total | +18.52K | $8.10K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common stock, $0.0001 par value
IndirectShares owned450.00
Total
450.00 indirect450.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common stock, $0.0001 par value | 450.00 | Indirect |
| Total | 450.00 | 450.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported